Javed Siddiqui

Active 1988–2025

82
Papers
24,589
Citations
66
h-index
81
i10-index

Citations

Citations per year for Javed Siddiqui1985: 1 citations1989: 5 citations1990: 9 citations1991: 7 citations1992: 8 citations1993: 9 citations1994: 3 citations1995: 1 citations1996: 5 citations1997: 9 citations1998: 10 citations1999: 8 citations2000: 6 citations2001: 5 citations2002: 6 citations2003: 18 citations2004: 23 citations2005: 27 citations2006: 30 citations2007: 34 citations2008: 36 citations2009: 57 citations2010: 53 citations2011: 88 citations2012: 179 citations2013: 310 citations2014: 357 citations2015: 398 citations2016: 476 citations2017: 456 citations2018: 449 citations2019: 1,128 citations2020: 1,118 citations2021: 1,026 citations2022: 706 citations2023: 510 citations2024: 727 citations2025: 283 citations2026: 3 citations1986–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,678 citing papers, 31.9% of this breakdownChina: 1,361 citing papers, 11.8% of this breakdownUnited Kingdom: 723 citing papers, 6.3% of this breakdownCanada: 558 citing papers, 4.8% of this breakdownItaly: 523 citing papers, 4.5% of this breakdownGermany: 485 citing papers, 4.2% of this breakdownFrance: 364 citing papers, 3.2% of this breakdownAustralia: 310 citing papers, 2.7% of this breakdownSpain: 307 citing papers, 2.7% of this breakdownJapan: 306 citing papers, 2.7% of this breakdownNetherlands: 259 citing papers, 2.3% of this breakdownSwitzerland: 209 citing papers, 1.8% of this breakdown
0%31.9%Other 21.1%

Fields

  • Medicine50.2%
  • Biochemistry, Genetics and Molecular Biology43%
  • Immunology and Microbiology2.9%
  • Chemistry0.8%
  • Computer Science0.7%
  • Neuroscience0.5%
  • Other1.9%

Topics

  • Prostate Cancer Treatment and Research9.6%
  • Cancer Genomics and Diagnostics4.4%
  • Prostate Cancer Diagnosis and Treatment4.3%
  • Cancer-related molecular mechanisms research4.1%
  • RNA modifications and cancer2.8%
  • Epigenetics and DNA Methylation2.2%
  • Other72.6%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. The mutational landscape of lethal castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 2,607

  3. Integrative clinical genomics of metastatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Moshe Talpaz, Marcin Cieslik, Arul M. Chinnaiyan - Nature, Nat. 2017 cited by 938

  4. Activating ESR1 mutations in hormone-resistant metastatic breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 1,158

  5. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  6. Identification of Targetable FGFR Gene Fusions in Diverse Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 738

  7. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2011 cited by 1,035

  8. Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisabeth I. Heath, Daniel J. Klionsky, Weiping Zou, Arul M. Chinnaiyan - Nature Cancer 2021 cited by 104

  9. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 683

  10. CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2019 cited by 132

  11. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 819

  12. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment

    Authors: , , , , , , , , , , , - European Urology 2015 cited by 394

  13. Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 cited by 158

  14. A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 59

  15. Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality

    Authors: , , , - The Journal of Immunology 2006 cited by 504

  16. The Role of Sarcosine Metabolism in Prostate Cancer Progression

    Authors: , , , , , , , , , , , , - Neoplasia 2013 cited by 179

  17. Next-generation RNA Sequencing–based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms

    Authors: , , , , , , , , , , , , , , , , - European Urology 2020 cited by 93

  18. Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 210

  19. Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2011 cited by 351

  20. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 270

  21. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing

    Authors: , , , , , , , , , , , , , - Genome Research 2015 cited by 191

  22. Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 88

  23. Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2011 cited by 421

  24. Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Seth Sadis, Daniel R. Rhodes, Scott A. Tomlins - Neoplasia 2015 cited by 227